Search
Now showing items 141-150 of 172
CA125 levels among patients with advanced heart failure: An emerging independent predictor for survival
(ELSEVIER IRELAND LTD, 2010)
…
Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure
(TEXAS HEART INST, 2017)
Length of stay is the primary driver of heart-failure hospitalization costs. Because cancer antigen 125 has been associated with poor morbidity and mortality rates in heart failure, we investigated the relationship between ...
In vivo and in vitro evidence for pleiotropic effects of levosimendan in the intensive care setting
(BIOMED CENTRAL LTD, 2011)
Levosimendan, in addition to its inotropic properties, could have anti-inflammatory and anti-oxidative properties, and can potentially decrease the deleterious effects of reactive oxygen species on the tissues. In their ...
Role of mean platelet volume in triagging acute coronary syndromes
(SPRINGER, 2008)
Background: Acute coronary syndromes, characterized by the rupture of unstable plaque and the subsequent thrombotic process involving platelets, have been increasing in relative frequency. The central role of platelet ...
Cytokines: Potential contributors to arrhythmogenesis in demyelinating syndromes?
(ELSEVIER IRELAND LTD, 2011)
…
Statins and aortic stenosis in the context of ratio of low- to high-density lipoprotein cholesterol
(ELSEVIER SCIENCE INC, 2007)
…
Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter?
(AVES YAYINCILIK, 2010)
Objective: Leyosimendan is a relatively new inotropic agent. Unlike other inotropic agents, Levosimendan does not increase cellular calcium intake, so that, does not cause intracellular calcium overload and related ...
Carbohydrate Antigen-125 Is a Mirror of Both Left and Right Sides of the Heart
(TEXAS HEART INST, 2012)
…
Acute Effects of Levosimendan and Dobutamine on QRS Duration in Patients with Heart Failure
(ARQUIVOS BRASILEIROS CARDIOLOGIA, 2010)
Background: Levosimendan is a novel inotropic agent that enhances cardiac contractility without increasing cellular calcium intake, so that it is not supposed to cause intracellular calcium overload and related arrhythmias. ...